AMBS applied for a Rare Pediatric Designation, (RPD), NOT A VOUCHER. The voucher is granted upon APPROVAL , which will be years away. They haven't even started the trial. If the voucher is granted in the future, it could be worth a lot of money, but of course it will not mean much if we are sitting with several billion shares.
(3)
(2)
Amarantus Bioscience Holdings (AMBS) Stock Research Links